A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Phase 1 study, condition: Healthy, Renal Insufficiency. The main purpose of this study is to assess the amount of study drug that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment compared to healthy participants. The study will last up to 5 weeks, excluding screening. Enrolment: 29 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.